According to the topline results of Phase-3 TRIUMPH-2 study, after 80 weeks of treatment, the once-weekly drug highest strength 12 mg helped patients to shed 20.8 per ent (22.5 kg) of their body weight, followed by 19.1 per cent (20.6 kg) and 12.7 per cent (13.5 kg) with the 9 mg and 4 mg dose respectively
Mitochondrial and Cellular Benefits: Microdosing GLP-1 agonists may enhance how your cells make energy and protect against cellular aging
But after some digging, I found people who had made it work, and the benefits they described sounded too good to ignore: clearer skin, reduced inflammation, increased energy, fat loss, better focus, and even improved sleep
Appetite-mediated portion reduction is the medication working as designed
doi: 10.3390/molecules28124839 99